• Explore /
  • Poster
  • / Assessing the impact on morbidity and mortality of neoadjuvant chemotherapy in patients with high-risk and muscle invasive bladder cancer eligible for radical cystectomy.

Assessing the impact on morbidity and mortality of neoadjuvant chemotherapy in patients with high-risk and muscle invasive bladder cancer eligible for radical cystectomy.

Abstract Poster

Authors

null

Ettore Di Trapani

Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy

Ettore Di Trapani , Rafael Sanchez-Salas , Lorenzo Rocchini , Giorgio Gandaglia , Marco Moschini , Daphne Lizee , Eric Barret , Francois Rozet , Marc Galiano , Renzo Colombo , Alberto Briganti , Francesco Montorsi , Xavier Cathelineau

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Testicular, and Urethral Cancers, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Urothelial Carcinoma

Citation

J Clin Oncol 33, 2015 (suppl 7; abstr 331)

DOI

10.1200/jco.2015.33.7_suppl.331

Abstract #

331

Poster Bd #

F19

Abstract Disclosures

Similar Posters

First Author: Andrea Necchi

First Author: Chiara Mercinelli

First Author: Patrick Squires

Poster

2023 ASCO Annual Meeting

The impact of neoadjuvant chemotherapy on 30-day radical cystectomy outcomes.

The impact of neoadjuvant chemotherapy on 30-day radical cystectomy outcomes.

First Author: Kerith Ruoyao Wang